CYH Stock Forecast & Price Target

Community Health System is positioned for improvement because management is driving cost reductions, portfolio repositioning, and ASC expansion while benefiting from same-store admissions and adjusted admissions growth of +1.9% and +2.9% y/y in the cited period. It also has a strong rural and suburban franchise, ongoing transfer-center initiatives, and investments in higher-acuity service lines that should support volume migration, elective procedure recovery, and better market share over time. Despite near-term margin pressure, its reaffirmed FY26 revenue of $11.6B-$12.0B and adjusted EBITDA of $1.34B-$1.49B, along with $1.1B+ gross proceeds from divestitures and $712M cash, suggest improving financial flexibility and execution potential.

Community Health System is facing a negative fundamental setup because its earnings power is being pressured by a wider ePTC headwind, persistent surgical softness, and an unfavorable payor and service mix that drove full-year adjusted EBITDA guidance down to $1.300–$1.375B. The 2Q print showed revenue below expectations at $2.83B and uncompensated care rising to 32.9% of revenue, while higher medical specialist fees, especially anesthesiology and radiology, are eroding margin improvement despite some labor and supply cost benefits. Although SDP benefits and an improving balance sheet offer partial support, the company’s highly leveraged balance sheet, reimbursement exposure, and volume uncertainty leave cash flow and valuation vulnerable.